ADC Therapeutics SA
ADCT
$1.16
-$0.075-6.10%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 250.87M | 274.27M | 300.12M | 234.29M | 278.60M |
| Total Receivables | 20.32M | 24.03M | 22.87M | 23.19M | 25.18M |
| Inventory | 18.39M | 16.07M | 15.19M | 16.00M | 16.18M |
| Prepaid Expenses | 8.37M | 18.63M | 17.18M | 16.74M | 10.34M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.45M | -- | -- | -- | 5.99M |
| Total Current Assets | 307.39M | 333.01M | 355.36M | 290.21M | 336.29M |
|
|
|||||
| Total Current Assets | 307.39M | 333.01M | 355.36M | 290.21M | 336.29M |
| Net Property, Plant & Equipment | 13.43M | 14.91M | 15.17M | 15.84M | 16.13M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.16M | 1.17M | 992.00K | 986.00K | 711.00K |
| Total Assets | 321.98M | 349.08M | 371.78M | 307.97M | 354.78M |
|
|
|||||
| Total Accounts Payable | 18.03M | 14.37M | 10.71M | 14.32M | 15.57M |
| Total Accrued Expenses | 49.82M | 40.07M | 34.57M | 35.54M | 39.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.37M | 8.70M | 1.42M | 1.43M | 1.47M |
| Total Finance Division Other Current Liabilities | 11.25M | 4.54M | 10.94M | 11.70M | 11.50M |
| Total Other Current Liabilities | 11.25M | 4.54M | 10.94M | 11.70M | 11.50M |
| Total Current Liabilities | 80.47M | 67.68M | 57.63M | 62.99M | 67.67M |
|
|
|||||
| Total Current Liabilities | 80.47M | 67.68M | 57.63M | 62.99M | 67.67M |
| Long-Term Debt | 433.73M | 436.81M | 429.88M | 423.24M | 416.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.00M | 8.88M | 9.31M | 9.66M | 10.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.43M | 7.65M | 6.62M | 6.52M | 8.88M |
| Total Liabilities | 524.62M | 521.03M | 503.45M | 502.42M | 503.03M |
|
|
|||||
| Common Stock & APIC | 1.29B | 1.29B | 1.29B | 1.19B | 1.19B |
| Retained Earnings | -1.49B | -1.46B | -1.42B | -1.38B | -1.34B |
| Treasury Stock & Other | -1.64M | -19.00K | -577.00K | -703.00K | -634.00K |
| Total Common Equity | -202.64M | -171.95M | -131.67M | -194.45M | -148.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -202.64M | -171.95M | -131.67M | -194.45M | -148.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -202.64M | -171.95M | -131.67M | -194.45M | -148.25M |
|
|
|||||
